Scientists track new Drug's journey through the body
NCT ID NCT07423286
Summary
This early-stage study aims to understand how a new Pfizer drug is absorbed and processed by the body. Eight healthy adult volunteers will take the drug by mouth and through an IV, with a tiny radioactive marker added to track its path. Researchers will collect blood, urine, and stool samples to measure how much drug enters the bloodstream and how the body eliminates it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fortrea Clinical Research Unit - Madison
Madison, Wisconsin, 53704, United States
-
Fortrea Clinical Research Unit Inc.
Madison, Wisconsin, 53704, United States
Conditions
Explore the condition pages connected to this study.